A 78-year-old man with non-valvular atrial fibrillation, hypertension, diabetes and prior transient ischaemic attack is seen in clinic. He is independent in activities of daily living and has no major bleeding history. His CHA2DS2-VASc score is 5. What is the most appropriate antithrombotic strategy?